Investigation of serum oxidative stress levels in patients with nasal polyps

Yıl 2018, Cilt: 45 Sayı: 1, 1 - 7, 17.03.2018

Adnan Ekinci

https://doi.org/10.5798/dicletip.407237

Cited By: 1

Öz

Objective:  To  compare  serum  total  antioxidant  status  (TAS),  total  oxidant  status  (TOS),  and  paraoxonase  (PON1) levels between nasal polyp patients and heal thy subjects.

Method: In the present study, The nasal polyp group includes 26 males an 22 females, a total of 48 patients (mean age 37.11±12.07 years), while the control group included 22 males and 24 females, a total of 46 healthy subjects (mean age 36.91±13.03) years. Groups were compared in terms of serum TAS, TOS and PON1 levels.

Results:  The  mean  TAS  level  was  1.248  mmol/L  in  the  control  group,  it  was  1.176  mmol/L  in  the  patient  group (p=0.044). The mean TOS level was 3.443 mmol/L in the control group, and it was 6.720 mmol/L in the patient group (p=006).  Nasal  polyp  and  control  groups  did  not  show  any  significant  difference  for  PON1  (301.15  U/L  vs.  295.75 U/L,p>0.05). 

Conclusion: Serum TOS levels were significantly higher, and TAS levels were significantly lower in patients with nasal polyposis  compared  it  the  control  group.  There  was  no  significant  difference  between  the  patients  with  nasal polypand the control group in terms of the PON1 values.

Anahtar Kelimeler

Nasal Polyp, Total Oxidant Status, Total Antioxidant Status

Kaynakça

• 1. Koc C: Nazal Polip, otolaryngology, head and neck surgery. (Ed. Koc C), Ankara, Güneş bookstore 2004; 609–624.
• 2. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol. 2003; 117: 1–9.
• 3. Karlıdag T, İlhan N, Kaygusuz İ, Keles E, Yalçin S, Yildiz M. Roles of free radicals, nitricoxide and scavenging enzymes in nasal polyp development. Ann Otol Rhinol Laryngol. 2005; 114:122–6.
• 4. Uslu C, Taysı S, Bakan N. Lipid peroxidation and some antioxidant enzyme activities in experimental maxillary sinusitis. Ann Clin Lab Sci. 2003;33:18–22.
• 5. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsöö B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stage. Laryngoscope. 1996; 106:196–203.
• 6. Si-es H. Oxidants and antioxidants. Exp Physiol. 1997; 82: 291-5.
• 7. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38: 1103-11.
• 8. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004; 37:112-19.
• 9. Ozdin M. Gursu M.F. Investigation of paraoxonase 1 and arylesterase activities and phenotypes in patients with coronary heart disease and various risk factors. Expertise Thesis, Fırat Universıty, Faculty of Medicine, Biochemistry Department, Elazıg, Turkey. 2003;17-19.
• 10. Durrington PN, Mackness B, Mackness MI. Paraoxonase and Atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:473-80.
• 11. Bozkus F, San, T. Ulas T, et al. Evaluation of total oxidative stress parameters in patients with nasal polyps. Acta Otorhinolaryngol Ital. 2013; 33:248-53.
• 12. Dogruer ZN, Unal M, Eskandari G, et al. Malon- dialdehyde and antioxidant enzymes in children with obstructive adenotonsillar hypertrophy. Clin Biochem. 2004; 37: 718–21.
• 13. Del Ben M, Fabiani M, Loffredo L, et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med. 2012; 23:12–36.
• 14. Sandikci R, Turkmen S, Guvenen G, et al. Lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet’s disease. Acta Derm Venereol. 2003; 83:342-6.
• 15. Hao W, Zhu Y, Meng L, Ni C, Yang J, Zhou H. Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp. Eur Arch Otorhinolaryngol. 2013; 270:1861–5.
• 16. Hartnell A, Heinemann A, Dolores M, et al. Identification of selective basophil chemo attractants in human nasal polyps as insulin-like growth factor–1 and insulin-like growth factor–2. J Immunol. 2004; 173:10,6448–57.
• 17. Daglı M, Eryılmaz A, Besler T, Akmansu H, Acar A, Korkmaz H. Role of free radicals and antioxidants in nasal polyps. Laryngoscope. 2004;114:1200–3.
• 18. Taysı S, Uslu C, Yılmaz A, Aktan A, Aktan B, Altas E. Lipid peroxidation and some antioxidant enzymes in nasal polyp tissue. Cell Biochem Funct. 2006; 24:461-5.
• 19. Cheng YK, Hwang GY, Lin CD, Tsai MH, Tsai SW, Chang WC. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients. Laryngoscope. 2006;116:417-22.